Loading
OT
Orexigen Therapeutics, Inc. Stock: price and insider trades · United States
Orexigen Therapeutics, Inc.: what insiders have been doing
Only a handful of insider records exist for Orexigen Therapeutics, Inc., the last one from 4 February 2016, too few to describe a trend. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
5
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Last declaration on 4 February 2016
Declarations5 total
5,091 sharesCommon StockSEC:0001209191-16-095646:0
1,860 sharesCommon StockSEC:0001209191-16-095647:0
4,170 sharesCommon StockSEC:0001209191-16-095647:1
721 sharesCommon StockSEC:0001209191-16-095645:0
1,761 sharesCommon StockSEC:0001209191-16-095645:1
5 of 5 declarations
About Orexigen Therapeutics, Inc.
Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on developing treatments for obesity. It is listed on NASDAQ under the ticker OREX.
